Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Trial of IMBCAMS Inactivated SARS-CoV-2 Vaccine (Covidful)
NCT04659239Phase 3Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jan 2021
- Primary completion
- Sep 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of Covidful in coronavirus disease 2019 (COVID-19), sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
Covidful
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04659239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04659239.